Streetbeat News

Stock Prices

CTSH

Analysts have provided various ratings for Cognizant Tech Solns (NASDAQ:CTSH) within the last quarter, with 1 bullish, 2 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target for the company is $74.0, an increase of 11.56% from the previous average price target of $66.33.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

STZ

Constellation Brands (NYSE:STZ) has outperformed the market over the past 15 years, producing an average annual return of 21.62%. If an investor had bought $1000 of STZ stock 15 years ago, it would be worth $18,296.38 today.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

UNP

Union Pacific's (NYSE:UNP) short percent of float has risen 16.0% since its last report, with 5.32 million shares sold short, which is 0.87% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. Union Pacific's peer group average for short interest as a percentage of float is 1.04%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

POR

Over the past 3 months, 6 analysts have published their opinion on Portland Gen Electric (NYSE:POR) stock. The analysts have an average price target of $44.5 versus the current price of $40.48, implying upside. This current average has decreased by 5.98% from the previous average price target of $47.33.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

HXL

Hexcel (NYSE:HXL) is set to release its latest quarterly earnings report on Monday, 2023-10-23, with analysts estimating an earnings per share (EPS) of $0.43. Last quarter, Hexcel beat EPS estimates by $0.02, but this was followed by a 5.44% drop in the share price. Over the last 52-week period, Hexcel shares are up 11.2%.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

MPC

Marathon Petroleum (NYSE:MPC) has outperformed the market over the past 5 years, producing an average annual return of 16.02%. If an investor had bought $100 of MPC stock 5 years ago, it would be worth $204.45 today.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

SOLUSD

Solana's (CRYPTO: SOL) price has risen 10.1% to $27.06 in the past 24 hours, continuing its positive trend over the past week with a 26.0% gain. The coin's all-time high is $259.96. The trading volume for the coin has increased 318.0% over the past week, while the overall circulating supply of the coin has decreased 0.23%. The current market cap ranking for SOL is #8 at $11.26 billion.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

AR

In the last quarter, Antero Resources (NYSE:AR) received 6 bullish and 4 indifferent analyst ratings. The company's average 12-month price target is $32.1, which has increased by 1.58% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

XRPUSD

XRP's price has increased by 6.75% over the past 24 hours to $0.52, and by over 8.0% over the past week. The trading volume for the coin has risen 203.0% over the past week, while the circulating supply has decreased by 0.29%. The current market cap ranking for XRP is #5 at $27.72 billion.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 3:00 pm

AZN

DSKYF

MRK

Merck & Company, Inc. (MRK) and Japan's Daiichi Sankyo Co. Ltd. (DSKYF) have entered into a global development and commercialization agreement for three of Daiichi Sankyo's DXd antibody-drug conjugate (ADC) candidates for multiple types of cancer. Merck will pay Daiichi Sankyo $5.5 billion in the agreement, which has a total potential consideration of up to $22 billion. Daiichi Sankyo aims for at least $6 billion of revenue from its oncology business in the fiscal year ending March 31, 2026.

Portfolio Pulse from Nabaparna Bhattacharya

October 20, 2023 | 2:59 pm